{{Rsnum
|rsid=2456973
|Gene=IKZF4
|Chromosome=12
|position=56023144
|Orientation=minus
|GMAF=0.2424
|Gene_s=IKZF4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 12.5 | 32.8 | 54.7
| HCB | 8.9 | 37.8 | 53.3
| JPT | 4.4 | 42.2 | 53.3
| YRI | 0.0 | 24.6 | 75.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 8.9 | 37.8 | 53.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22561518
|Trait=None
|Title=Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.
|RiskAllele=C
|Pval=3E-14
|OR=1.2900
|ORtxt=None
|OA=1
}}{{PMID Auto
|PMID=20668683
|Title=Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes risk.
|OA=1
}}